|
Anapafseos 5 Agios Nikolaos 72100,Crete,Greece,00302841026182,00306932607174,alsfakia@gmail.com
Blog Archive
- ► 2022 (3010)
-
▼
2021
(9899)
-
▼
July
(937)
-
▼
Jul 12
(25)
- Alpelisib and radiotherapy treatment enhances Alis...
- IL-17 signaling pathway plays a key role in laryng...
- Genetic variants of EML1 and HIST1H4E in myeloid c...
- Prognostic stratification based on a novel nomogra...
- Deletion of Foxa1 in the mouse mammary gland resul...
- Differential molecular response of larynx cancer c...
- Inhibition of P53-mediated cell cycle control as t...
- Integrative multiplatform-based molecular profilin...
- A phase 1, multicenter study evaluating the safety...
- Targeting ERK combined with apatinib may be a prom...
- Frailty is associated with mortality in brain tumo...
- Epigenetic heterogeneity promotes acquired resista...
- Irreversible electroporation enhances immunotherap...
- Hypoxia-induced lncRNA CASC9 enhances glycolysis a...
- Low expression of miR-195 is associated with cell ...
- OX40 agonist combined with irreversible electropor...
- SERMs suppresses the growth of ERalpha positive ce...
- HP1BP3 promotes tumor growth and metastasis by upr...
- DLX5 promotes osteosarcoma progression via activat...
- Predicting early recurrence for resected pancreati...
- MicroRNA-613 suppresses proliferation, migration a...
- A heptamethine cyanine dye serves as a potential m...
- MicroRNA-122 inhibits proliferation and invasion i...
- A novel mechanism driving poor-prognostic gastric ...
- Muscle weakness caused by cancer and chemotherapy ...
-
▼
Jul 12
(25)
-
▼
July
(937)
- ► 2020 (4138)
- ► 2019 (2429)
Αλέξανδρος Γ. Σφακιανάκης
Monday, July 12, 2021
MicroRNA-122 inhibits proliferation and invasion in gastric cancer by targeting CREB1 [Retraction]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment